As global markets continue to climb, with small-cap indices like the Russell 2000 reaching record highs amid a backdrop of geopolitical and domestic policy influences, investors are keenly observing how these dynamics impact high-growth sectors. In this environment, identifying tech stocks with strong growth potential can be crucial for portfolio enhancement, especially as economic indicators highlight resilience in consumer spending despite ongoing manufacturing challenges.
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Material Group | 20.45% | 24.01% | ★★★★★★ |
eWeLLLtd | 27.24% | 28.74% | ★★★★★★ |
Waystream Holding | 22.09% | 113.25% | ★★★★★★ |
Pharma Mar | 25.97% | 56.89% | ★★★★★★ |
Medley | 25.57% | 31.67% | ★★★★★★ |
CD Projekt | 21.20% | 28.62% | ★★★★★★ |
TG Therapeutics | 34.66% | 56.98% | ★★★★★★ |
Elliptic Laboratories | 70.09% | 111.37% | ★★★★★★ |
Alkami Technology | 21.89% | 98.60% | ★★★★★★ |
Initiator Pharma | 73.95% | 31.34% | ★★★★★★ |
Click here to see the full list of 1288 stocks from our High Growth Tech and AI Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Serko Limited is a Software-as-a-Service technology company that offers online travel booking software solutions and expense management services across New Zealand, Australia, North America, Europe, and other international markets, with a market cap of NZ$449.50 million.
Operations: Serko generates revenue primarily through its provision of software solutions, amounting to NZ$74.45 million. The company focuses on delivering online travel booking and expense management services across multiple regions globally.
Serko's trajectory in the high-growth tech sector is marked by a robust revenue increase forecast at 21.2% annually, outpacing the New Zealand market's 4.2% growth rate. Despite current unprofitability, earnings are expected to surge by approximately 64.5% per year, positioning Serko for potential profitability within three years. This optimistic outlook is underpinned by significant R&D investments which underscore the company’s commitment to innovation and market expansion, crucial for maintaining competitiveness in the fast-evolving tech landscape. Recent executive changes and a positive half-year financial report suggest strategic realignments and operational improvements that could further enhance its market stance and future prospects.
Understand Serko's track record by examining our Past report.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Horizon Robotics, listed under ticker SEHK:9660, is an investment holding company that specializes in providing automotive solutions for passenger vehicles in China, with a market capitalization of approximately HK$53.29 billion.
Operations: The company generates revenue primarily from automotive solutions, accounting for CN¥2.04 billion, while non-automotive solutions contribute CN¥76.26 million.
Horizon Robotics, recently bolstered by a HKD 5.41 billion IPO, is poised for significant growth with revenue expected to surge by 36.2% annually, outstripping the Hong Kong market's 7.8% expansion rate. This growth trajectory is underpinned by a robust focus on R&D, where investments are crucial for maintaining its competitive edge in AI technologies. The company's recent amendments to its bylaws and successful public listing underscore a strategic positioning aimed at capitalizing on burgeoning demand for intelligent computing solutions across various sectors. With earnings projected to grow at an impressive rate of 87.4% per year, Horizon Robotics is navigating towards profitability within the next three years, reflecting both the high-potential nature of its offerings and its operational enhancements post-IPO.
Gain insights into Horizon Robotics' past trends and performance with our Past report.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Chunghwa Precision Test Tech. Co., Ltd., along with its subsidiaries, specializes in the testing of semiconductor components both within Taiwan and internationally, with a market cap of NT$23.94 billion.
Operations: The company generates revenue primarily from its electronic components and parts segment, amounting to NT$3.09 billion. With a focus on semiconductor testing, it operates both domestically and internationally.
Chunghwa Precision Test Tech has demonstrated a remarkable financial trajectory with its third-quarter sales soaring to TWD 916.96 million, up from TWD 692.37 million the previous year, and net income skyrocketing to TWD 106.69 million from TWD 10.9 million. This surge is underpinned by a robust R&D commitment, crucial for sustaining its competitive edge in precision testing technologies within the tech sector. Looking ahead, with earnings forecasted to grow by an impressive 74.7% annually and revenue expected to increase by 24.4% per year, Chunghwa stands well-positioned to capitalize on expanding market demands, especially noted during their recent presentation at Citi's Taiwan Corporate Day.
Examine Chunghwa Precision Test Tech's past performance report to understand how it has performed in the past.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NZSE:SKO SEHK:9660 and TPEX:6510.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.